Free Trial

180 Life Sciences (ATNFW) Competitors

180 Life Sciences logo
$0.55 +0.44 (+416.43%)
As of 04:00 PM Eastern

ATNFW vs. LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying 180 Life Sciences stock or one of its competitors? The main competitors of 180 Life Sciences include 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

180 Life Sciences vs. Its Competitors

4D pharma (NASDAQ:LBPSW) and 180 Life Sciences (NASDAQ:ATNFW) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Company Net Margins Return on Equity Return on Assets
4D pharmaN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4D pharma$522KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences had 4 more articles in the media than 4D pharma. MarketBeat recorded 4 mentions for 180 Life Sciences and 0 mentions for 4D pharma. 180 Life Sciences' average media sentiment score of 0.98 beat 4D pharma's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
4D pharma Neutral
180 Life Sciences Positive

Summary

180 Life Sciences beats 4D pharma on 2 of the 3 factors compared between the two stocks.

Get 180 Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATNFW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATNFW vs. The Competition

Metric180 Life SciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$138.24M$5.55B$9.83B
Dividend YieldN/A3.74%4.62%4.11%
P/E RatioN/A3.7830.1526.03
Price / SalesN/A4,243.32460.84105.55
Price / CashN/A13.1937.7558.93
Price / BookN/A41.548.476.06
Net IncomeN/A-$90.99M$3.26B$265.11M
7 Day PerformanceN/A0.82%3.56%2.90%
1 Month PerformanceN/A3.73%5.97%3.99%
1 Year PerformanceN/A180.18%42.70%26.92%

180 Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
N/A$0.55
+416.4%
N/A+1,183.1%$0.00N/A0.007News Coverage
Gap Up
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%
N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.11
-8.3%
N/A+514.3%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.60
-17.5%
N/A-42.4%$0.00$585.60M0.004Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
+2.9%
N/A-45.2%$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.15
-2.6%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.02
+19.3%
N/A-97.7%$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.03
-12.0%
N/A-84.5%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.05
-10.0%
N/AN/A$0.00$54.22M0.00220Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:ATNFW) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners